Research Shows High Diversity Among Malaria Parasites, Raises Questions For Control, Prevention Techniques

Bloomberg: DNA Fingerprinting Throws Doubt on Glaxo Malaria Vaccine Effort
“Groundbreaking research has shown the potentially deadly malaria parasite has greater genetic diversity than scientists previously understood, a finding that throws doubt on the efficacy of vaccines in development by companies such GlaxoSmithKline Plc. … The research, published Tuesday in the Proceedings of the National Academy of Sciences, is the first to rely on DNA fingerprinting to show how malaria’s genetic diversity enables it to evade the human immune system and establish a chronic infection…” (Gale, 5/3).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.